Highlights

[MERIDIAN] QoQ Quarter Result on 2020-06-30 [#0]

Stock [MERIDIAN]: MEDA INC BHD
Announcement Date 04-Sep-2020
Admission Sponsor -
Sponsor -
Financial Year 30-Jun-2020
30-Jun-2020
Profit Trend QoQ -     -62.96%    YoY -     1,217.89%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 6,952 611 7,454 4,121 665 970 7,971 -8.72%
  QoQ % 1,037.81% -91.80% 80.88% 519.70% -31.44% -87.83% -
  Horiz. % 87.22% 7.67% 93.51% 51.70% 8.34% 12.17% 100.00%
PBT 4,248 11,433 -11,199 38 -380 -3,170 -12,987 -
  QoQ % -62.84% 202.09% -29,571.05% 110.00% 88.01% 75.59% -
  Horiz. % -32.71% -88.03% 86.23% -0.29% 2.93% 24.41% 100.00%
Tax 0 37 -63 -8 0 0 -545 -
  QoQ % 0.00% 158.73% -687.50% 0.00% 0.00% 0.00% -
  Horiz. % -0.00% -6.79% 11.56% 1.47% -0.00% -0.00% 100.00%
NP 4,248 11,470 -11,262 30 -380 -3,170 -13,532 -
  QoQ % -62.96% 201.85% -37,640.00% 107.89% 88.01% 76.57% -
  Horiz. % -31.39% -84.76% 83.22% -0.22% 2.81% 23.43% 100.00%
NP to SH 4,248 11,470 -11,262 30 -380 -3,170 -13,871 -
  QoQ % -62.96% 201.85% -37,640.00% 107.89% 88.01% 77.15% -
  Horiz. % -30.63% -82.69% 81.19% -0.22% 2.74% 22.85% 100.00%
Tax Rate - % -0.32 % - % 21.05 % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% -1.52% 0.00% 100.00% - - -
Total Cost 2,704 -10,859 18,716 4,091 1,045 4,140 21,503 -74.93%
  QoQ % 124.90% -158.02% 357.49% 291.48% -74.76% -80.75% -
  Horiz. % 12.57% -50.50% 87.04% 19.03% 4.86% 19.25% 100.00%
Net Worth 147,288 141,396 135,505 113,287 113,287 113,287 118,213 15.80%
  QoQ % 4.17% 4.35% 19.61% 0.00% 0.00% -4.17% -
  Horiz. % 124.60% 119.61% 114.63% 95.83% 95.83% 95.83% 100.00%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div - - - - - - - -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 147,288 141,396 135,505 113,287 113,287 113,287 118,213 15.80%
  QoQ % 4.17% 4.35% 19.61% 0.00% 0.00% -4.17% -
  Horiz. % 124.60% 119.61% 114.63% 95.83% 95.83% 95.83% 100.00%
NOSH 589,153 589,153 589,153 492,555 492,555 492,555 492,555 12.69%
  QoQ % 0.00% 0.00% 19.61% 0.00% 0.00% 0.00% -
  Horiz. % 119.61% 119.61% 119.61% 100.00% 100.00% 100.00% 100.00%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 61.10 % 1,877.25 % -151.09 % 0.73 % -57.14 % -326.80 % -169.77 % -
  QoQ % -96.75% 1,342.47% -20,797.26% 101.28% 82.52% -92.50% -
  Horiz. % -35.99% -1,105.76% 89.00% -0.43% 33.66% 192.50% 100.00%
ROE 2.88 % 8.11 % -8.31 % 0.03 % -0.34 % -2.80 % -11.73 % -
  QoQ % -64.49% 197.59% -27,800.00% 108.82% 87.86% 76.13% -
  Horiz. % -24.55% -69.14% 70.84% -0.26% 2.90% 23.87% 100.00%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 1.18 0.10 1.27 0.84 0.14 0.20 1.62 -19.06%
  QoQ % 1,080.00% -92.13% 51.19% 500.00% -30.00% -87.65% -
  Horiz. % 72.84% 6.17% 78.40% 51.85% 8.64% 12.35% 100.00%
EPS 0.72 1.95 -1.91 0.01 -0.08 -0.64 -2.82 -
  QoQ % -63.08% 202.09% -19,200.00% 112.50% 87.50% 77.30% -
  Horiz. % -25.53% -69.15% 67.73% -0.35% 2.84% 22.70% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.2500 0.2400 0.2300 0.2300 0.2300 0.2300 0.2400 2.76%
  QoQ % 4.17% 4.35% 0.00% 0.00% 0.00% -4.17% -
  Horiz. % 104.17% 100.00% 95.83% 95.83% 95.83% 95.83% 100.00%
Adjusted Per Share Value based on latest NOSH - 589,153
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 1.18 0.10 1.27 0.70 0.11 0.16 1.35 -8.59%
  QoQ % 1,080.00% -92.13% 81.43% 536.36% -31.25% -88.15% -
  Horiz. % 87.41% 7.41% 94.07% 51.85% 8.15% 11.85% 100.00%
EPS 0.72 1.95 -1.91 0.01 -0.06 -0.54 -2.35 -
  QoQ % -63.08% 202.09% -19,200.00% 116.67% 88.89% 77.02% -
  Horiz. % -30.64% -82.98% 81.28% -0.43% 2.55% 22.98% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.2500 0.2400 0.2300 0.1923 0.1923 0.1923 0.2006 15.82%
  QoQ % 4.17% 4.35% 19.60% 0.00% 0.00% -4.14% -
  Horiz. % 124.63% 119.64% 114.66% 95.86% 95.86% 95.86% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 0.0800 0.0550 0.0650 0.0750 0.2450 0.2950 0.2950 -
P/RPS 6.78 53.03 5.14 8.96 181.47 149.80 18.23 -48.31%
  QoQ % -87.21% 931.71% -42.63% -95.06% 21.14% 721.72% -
  Horiz. % 37.19% 290.89% 28.20% 49.15% 995.45% 821.72% 100.00%
P/EPS 11.10 2.83 -3.40 1,231.39 -317.57 -45.84 -10.48 -
  QoQ % 292.23% 183.24% -100.28% 487.75% -592.78% -337.40% -
  Horiz. % -105.92% -27.00% 32.44% -11,749.91% 3,030.25% 437.40% 100.00%
EY 9.01 35.40 -29.41 0.08 -0.31 -2.18 -9.55 -
  QoQ % -74.55% 220.37% -36,862.50% 125.81% 85.78% 77.17% -
  Horiz. % -94.35% -370.68% 307.96% -0.84% 3.25% 22.83% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.32 0.23 0.28 0.33 1.07 1.28 1.23 -59.28%
  QoQ % 39.13% -17.86% -15.15% -69.16% -16.41% 4.07% -
  Horiz. % 26.02% 18.70% 22.76% 26.83% 86.99% 104.07% 100.00%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 04/09/20 26/06/20 28/02/20 19/11/19 30/08/19 30/05/19 27/02/19 -
Price 0.2650 0.0800 0.0850 0.0650 0.0900 0.2450 0.2850 -
P/RPS 22.46 77.14 6.72 7.77 66.66 124.41 17.61 17.62%
  QoQ % -70.88% 1,047.92% -13.51% -88.34% -46.42% 606.47% -
  Horiz. % 127.54% 438.05% 38.16% 44.12% 378.53% 706.47% 100.00%
P/EPS 36.75 4.11 -4.45 1,067.20 -116.66 -38.07 -10.12 -
  QoQ % 794.16% 192.36% -100.42% 1,014.80% -206.44% -276.19% -
  Horiz. % -363.14% -40.61% 43.97% -10,545.45% 1,152.77% 376.19% 100.00%
EY 2.72 24.34 -22.49 0.09 -0.86 -2.63 -9.88 -
  QoQ % -88.82% 208.23% -25,088.89% 110.47% 67.30% 73.38% -
  Horiz. % -27.53% -246.36% 227.63% -0.91% 8.70% 26.62% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.06 0.33 0.37 0.28 0.39 1.07 1.19 -7.43%
  QoQ % 221.21% -10.81% 32.14% -28.21% -63.55% -10.08% -
  Horiz. % 89.08% 27.73% 31.09% 23.53% 32.77% 89.92% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS